Arnoud Den Ouden Email & Phone Number

Hoofddorp, North Holland, Netherlands

Driving and operationalising country activity and local strategies, ensuring business and commercial goals are met. This will be achieved via close collaboration and effective cross functional working with the wider KKI Team, the Cluster, and of course with all key external stakeholders, HCPs and PAGs.

Brussels, Brussels Region, Belgium

As of August 2023, I'm proud to be leading the business of rare diseases for Pfizer Belgium & Luxembourg, managing a successful portfolio of inline brands, combined with the wonderful prospect of pioneering the science of breakthroughs and aspiring to be the world’s leading innovator in rare disease.

Brussels, Brussels Region, Belgium

Accountable for the Covid franchise for Belgium & Luxembourg. Working with a very talented team to partner with a variety of external and internal stakeholders on the prevention and treatment of covid-19.

Belgium

From the 3rd January 2022, I’m happy and excited to lead the Inflammation & Immunology (I&I) business and commercial organisation in Belgium, one of I&I’s largest and fastest growing markets in Mid-Sized Europe. Building on recent experiences in Germany, Sweden and Finland, this role holds responsibility for delivering the revenue and IBT targets, incl..

Netherlands

From 1st May 2021, I’m leading the Inflammation & Immunology business for Sweden and Finland, as I&I SE-FI sub-Cluster Lead. This role holds responsibility for delivering the revenue and IBT targets for the sub-cluster, incl. full P&L management, and the development and execution of the annual and multi-year operating plan. In more detail, there’s a clear.

Global - Based In The Netherlands

From 1st January 2019, as the Global Commercial Performance Lead for the Inflammation & Immunology (I&I) portfolio, I’m providing commercial and strategic expertise and guidance for local implementation. With the focus on Enbrel and Biosimilars (eg Inflectra), I’m partnering with Country/Cluster I&I Leads across the world, and cross-functional partners (eg.

Based In The Netherlands

From mid-July till early November I’ve stepped in temporarily to cover the I&I Germany Lead role, while continuing my current global role as CPL for Enbrel and Biosimilars. The role included oversight of the business (~$250M revenue P&L; ~100 colleagues) and particularly the Op Planning 2021 process. Additionally, I've been focusing on the execution of.

Global - Based In The Netherlands

From 1st December 2017, I've joined the Global Biosimilars Team as Regional Lead (Global Commercial Lead). In this new role I have been responsible for driving business performance by ensuring consistent commercial and operational support for the Biosimilars portfolio across all regions globally: Europe, AsiaPacific, Latin America, Canada, Greater China.

Europe; Based In The Netherlands

As the Regional Business Director (RBD) Biosimilars, I’ve been focusing on our customers in relation to the biosimilars segment of the Pfizer PEH portfolio, to drive exceptional business performance and to meet ambitious business objectives for Europe, through knowledge, networking and innovation.Background:Biologics are medicines made from living cells.

Tadworth, UK; Hurley, UK

As we continued on our journey of fully integrating legacy Hospira into our Pfizer Essential Health (PEH) business, there was great excitement regarding the potential opportunities in 2016 at a business, people and capability level. To ensure a smooth journey and full engagement throughout this transition, I had been appointed as interim Project Lead per.

United Kingdom

In this role, I have been responsible for UK Global Established Pharma Business Operations, working closely with our Business Unit Head and Leadership team on a day-to-day basis as well as on key topics such as business reviews, operating plans and key business events. In parallel, I have been leading a team of experts (14 colleagues in total) for.

Europe

Peri-LoE Planning has been and still is critical to Pfizer’s future success. Between 2009 and 2014, a significant amount of "blockbusters" has reached the end of their patent and faced their loss of exclusivity (LoE). Therefore, Pfizer Established Products Europe had committed additional resources to Peri-LoE Planning in its new organizational structure..

Northern Europe

My responsibilities included a variety of projects, from divesting an older oncology product, exploring Business Development opportunities, sharing best practices regarding Tendering in Europe as well as Peri-LoE priorities, such as ensuring dual products for our upcoming LoE's (products losing patent exclusivity).

Rotterdam, Netherlands

Responsiblities (int.al.): Strategic customerplans and customermanager of GP’s, pharmacists, specialists and regional networks (especially. 1st line and transmural care).National Sales Manager Spiriva, co-promotion with partner Boehringer Ingelheim. Sparringpartner of Marketing in relation to the product- and customerstrategy. Selection and final decision.

Rotterdam Area, Netherlands

Sales/business responsible for one of the four regions in the Netherlands: South-West NL. Linemanager of four salesmanagers, each responsible within their district for the realisation of their sales- and customersatisfaction goals. FTE-responsibility: 50 people.

Rotterdam, Netherlands

Strategic projects towards a better, customer focussed, Pfizer.Managing Customer Networks:Identifying regional and national networks, the interaction between them and provide guiding principles on the proces how to organise customer (related) departments for these networks. Furthermore, we will define business needs (requirements) on infrastructure, people.

Netherlands

Salesmanager of two teams of five Regional Account Managers (Cardiovascular & Pain/Psychiatry/COPD). Process responsible for regional and national formulary- and FTO-policy (1st & 2nd line).

Pfizer Netherlands, Rotterdam

Build and maintain sustainable relationships with pharmaceutical wholesalers and parallel import/export firms in the Netherlands and negotiating margin-and price-agreements with them, for all Pfizer products; Responsible for all contracts with the buying groups of hospitals and individual hospitals in the Netherlands.

Region: Middle- And East Netherlands.

Account Manager, Pfizer Netherlands; Build and maintain sustainable relationships, negotiating price agreements and the promotion of all Pfizer-products with Dutch pharmacists and hospital pharmacists.

Maassluis, Netherlands

Clinical Sales rep, various products; finalisation of the traineeship by writing and presenting the brand operating plan of a cholesterol lowering product (a fibrate).

European Master In Law And Economics, Post Graduate Erasmus Program “Law And Economics”.

Post Graduate Erasmus Program “Law and Economics”: Rotterdam (Netherlands, Oct-Dec 1995) Ghent (Belgium, Jan-Mar 1996), Aix-en-Provence.

Leadership Course, Pfizer European Leadership Development Program

Pfizer Talent Program

Strategy Course, Strategy In The Pharmaceutical Industry

Pharma Educational Program

Masters, Economics

Business Economics, Erasmus University, Rotterdam. Degree: Master of Science

V.W.O, Atheneum

Secondary School